The signaling pathway involving galectin-9 and T cell immunoglobulin and mucin-domain-containing-3 (TIM-3) play a crucial regulatory role in CLL [15]. This evidence concerns the gene HAVCR2 and B-cell chronic lymphocytic leukemia.